结合学习方法与可解释的人工智能,改善心脏病预测.
Ayomide Adekoya1, Faisal Saeed1, Wad Ghaban2
1Department of Computer Science, Birmingham City University, Birmingham, United Kingdom.
Frontiers in pharmacology
|December 29, 2025
概括
可解释组合学习框架 (IELF) 通过结合可解释增强机器 (EBM) 和XGBoost来增强心脏病预测. 这种方法提高了对心血管风险评估的模型解释性和临床可靠性.
科学领域:
- 人工智能的人工智能
- 机器学习 机器学习
- 心血管医学 心血管医学
背景情况:
- 心脏病是全球主要的健康问题,推动了对准确和可解释的预测模型的需求.
- 现有的模型往往缺乏透明度,阻碍了临床信任和采用.
- 可解释的AI (XAI) 技术对于理解医疗保健中的模型决策至关重要.
研究的目的:
- 引入可解释组合学习框架 (IELF) 以提高心血管风险预测.
- 将可解释增强机 (EBM) 与XGBoost,SHAP和LIME集成,以提高本地解释性.
- 为心脏病学中翻译性AI建立一个可靠的基准.
主要方法:
- 在克利夫兰 (n=303) 和弗拉明汉 (n=4,240) 心脏病数据集上评估了IELF.
- 严格的验证包括5倍交叉验证,持久测试集,校准和子组分析.
- 使用肯德尔的t和Overlap@10指标来评估解释稳定性.
主要成果:
- IELF表现出强大的歧视,在克利夫兰获得0.899的AUC,在弗拉明汉获得0.696的AUC.
- 与弗雷明汉数据集上的EBM相比,该框架显著改善了回忆,F1得分和AUC (p <0.05).
- IELF提供了透明的特征排名,与已知的心血管风险因素保持一致,并提供了稳定的解释.
结论:
- IELF是第一个在严格的验证协议下将EBM和XGBoost与SHAP和LIME结合在一起的框架.
- 尽管标题准确度可能低于某些模型,但IELF优先考虑可重复性,可解释性和临床可靠性.
- IELF作为AI在心血管风险预测中的可靠基准,平衡性能与透明度.
相关概念视频
Overview of the Heart
12.4K
The heart, a muscular organ located in the chest, functions as the body's pump, circulating blood through the vascular system. It has four chambers: two atria on top and two ventricles below. The right atrium receives deoxygenated blood from the body and passes it to the right ventricle, which pumps it to the lungs for oxygenation. The left atrium receives oxygenated blood from the lungs and transfers it to the left ventricle, which pumps it to the rest of the body.
The heart's structure...
The heart's structure...
12.4K
Heart Failure I: Introduction
657
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
657
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Coronary Artery Disease I: Introduction
846
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
846

